infecti
conjunct
difficult
distinguish
clinic
due
consider
overlap
clinic
present
clinic
diagnosi
conjunct
often
insuffici
therefor
necessari
rapid
diagnost
test
differenti
differ
caus
infecti
conjunct
screen
clinic
sampl
sampl
typesyndrom
base
multiplex
real
time
pcr
would
allow
rapid
detect
varieti
pathogen
simultan
turn
aid
treatment
clinic
manag
patient
multiplex
realtim
pcr
assay
rapid
simultan
detect
hsv
vzv
adenoviru
chlamydia
trachomati
c
trachomati
eye
swab
develop
evalu
multiplex
assay
shown
sensit
specif
robust
reduct
sampl
turn
around
time
achiev
reduc
amount
separ
test
need
carri
crown
infecti
conjunct
common
caus
virus
bacteria
parasit
infect
usual
mild
howev
complic
aris
sightthreaten
infecti
conjunct
difficult
distinguish
clinic
due
consider
overlap
clinic
present
clinic
diagnosi
conjunct
often
insuffici
obrien
et
al
lead
misdiagnosi
result
misus
antibiot
antibiot
resist
subsequ
unnecessari
cost
thanathane
obrien
therefor
necessari
rapid
diagnost
test
differenti
differ
caus
infect
conjunct
tradit
detect
method
viru
detect
reli
often
slow
labori
insensit
cell
cultur
larg
replac
nucleic
acid
amplif
test
pcr
usual
carri
singl
test
pathogen
test
pathogen
alway
avail
site
screen
clinic
sampl
sampl
typesyndrom
base
multiplex
real
time
pcr
would
allow
rapid
detect
varieti
pathogen
simultan
turn
aid
treatment
clinic
manag
patient
multiplex
realtim
pcr
assay
rapid
simultan
detect
hsv
vzv
adenoviru
c
trachomati
eye
swab
develop
evalu
vzv
adenoviru
assay
use
multiplex
publish
previous
ryncarz
et
al
van
doornum
et
al
hawrami
breuer
heim
et
al
assay
shown
sensit
specif
detect
strain
c
trachomati
assay
develop
inhous
see
c
trachomati
assay
design
inhous
use
primer
express
tm
appli
biosystem
primer
probe
develop
target
cryptic
plasmid
sequenc
given
tabl
primer
probe
compar
sequenc
avail
blast
wwwncbinlmnihgovblast
shown
detect
serovar
c
trachomati
includ
swedish
variant
sw
c
trachomati
discov
interf
tabl
primer
probe
sequenc
public
secondari
structur
observ
use
mfold
algorithm
wwwbioinforpiedu
assess
c
trachomati
real
time
assay
endpoint
sensit
c
trachomati
assay
compar
fulli
autom
commerci
extract
realtim
pcr
system
abbott
realtim
chlamydia
trachomatisneisseria
gonorrhoea
ctng
pcr
assay
abbott
maidenhead
uk
compar
endpoint
sensit
use
dilut
seri
posit
clinic
sampl
c
trachomati
assay
evalu
use
qualiti
probe
label
differ
fluoresc
dye
tabl
case
hsv
hsv
probe
label
fluoresc
dye
enabl
detect
pathogen
one
multiplex
screen
also
reduc
risk
crosstalk
dye
inabl
differenti
hsv
discuss
user
prior
develop
user
agre
suffici
detect
hsv
dye
optimis
hsv
probe
ensur
probe
produc
similar
level
fluoresc
primer
probe
concentr
assay
singleton
multiplex
individu
optimis
use
inhous
protocol
gunson
et
al
primer
probe
shown
tabl
vzv
probe
primer
purchas
appli
biosystem
cheshir
uk
remain
probe
purchas
eurogentec
sera
belgium
optimis
concentr
probe
primer
endpoint
detect
limit
compon
multiplex
directli
compar
current
routin
singl
assay
use
dilut
seri
posit
control
target
carri
ensur
multiplex
assay
result
loss
sensit
endpoint
detect
interassay
intraassay
variabl
multiplex
also
assess
interassay
variabl
reproduc
longterm
precis
assess
monitor
posit
run
control
pcr
run
assess
whole
test
system
includ
extract
pcr
run
differ
user
intraassay
repeat
shortterm
precis
variabl
assess
test
posit
control
well
one
pcr
run
sampl
extract
either
qiagen
mdx
use
qiaamp
viral
rna
kit
qiagen
crawley
uk
nuclisen
easymag
hampshir
uk
accord
manufactur
instruct
extract
platform
compar
sensit
use
interchang
abbott
commerci
ctng
assay
use
abbott
autom
extract
platform
sampl
extract
pcr
perform
l
dna
extract
platinum
qpcr
pcr
mastermix
pcr
kit
invitrogen
abi
prism
sd
realtim
platform
appli
biosystem
l
reaction
volum
follow
thermal
profil
use
min
c
min
c
dna
polymeras
activ
follow
amplif
cycl
sec
c
sec
c
annealingextens
step
dilut
seri
assess
c
trachomati
assay
abbott
commerci
system
tabl
result
suggest
sensit
c
trachomati
assay
similar
abbott
system
c
trachomati
assay
detect
dilut
wherea
abbott
system
detect
dilut
howev
detect
beyond
cutoff
without
ct
valu
sampl
detect
beyond
cutoff
sampl
repeat
system
extract
pcr
sampl
determin
beyond
cutoff
repeat
sampl
report
posit
abbott
system
detect
dilut
beyond
cutoff
repeat
therefor
result
suggest
abbott
system
may
slightli
sensit
endpoint
detect
c
trachomati
assay
assess
use
qcmd
c
tracho
assay
also
evalu
use
panel
sda
posit
clinic
sampl
assay
detect
sda
posit
sampl
posit
endpoint
sensit
compar
endpoint
detect
limit
compon
multiplex
assay
singl
assay
show
multiplex
detriment
effect
endpoint
detect
limit
compon
tabl
adenoviru
singl
assay
detect
dilut
occas
multiplex
detect
dilut
test
dilut
seri
singl
assay
detect
dilut
multiplex
assay
detect
dilut
occas
singl
assay
multiplex
detect
dilut
occas
test
dilut
seri
vzv
singl
vzv
assay
detect
dilut
occas
multiplex
detect
dilut
c
trachomati
assay
detect
multiplex
assay
detect
occas
specif
assay
confirm
test
panel
commonli
encount
pathogen
fals
posit
result
encount
interassay
variabl
assess
monitor
posit
run
control
pcr
run
tabl
intraassay
variabl
test
posit
control
well
one
pcr
run
tabl
result
suggest
littl
interassay
variabl
ct
compon
similar
differ
run
low
standard
deviat
valu
low
coeffici
variat
c
v
valu
result
also
suggest
intraassay
variabl
assay
also
good
compon
littl
variat
observ
posit
control
repeatedli
test
low
c
v
valu
overal
result
suggest
duplex
assay
precis
robust
paper
describ
develop
valid
multiplex
realtim
pcr
assay
allow
rapid
simultan
detect
vzv
adenoviru
c
trachomati
eye
swab
valid
show
newli
design
c
trachomati
assay
sensit
specif
compar
abbott
system
hous
may
slightli
less
sensit
endpoint
detect
inhous
assay
therefor
may
occasion
miss
weak
posit
c
trachomati
sampl
multiplex
five
assay
effect
perform
individu
compon
assess
dilut
panel
multiplex
assay
shown
specif
assess
qualiti
control
panel
panel
commonli
encount
pathogen
multiplex
assay
also
shown
precis
robust
assess
interassay
intraassay
variabl
multiplex
sampl
typediseas
syndrom
simplifi
routin
servic
overal
cost
reduc
compar
singl
test
rapid
diagnosi
reduc
unnecessari
antibiot
usag
investig
reduct
sampl
turn
around
time
achiev
reduc
amount
separ
test
need
carri
ensur
sampl
test
within
work
day
gunson
et
al
sinc
introduct
realtim
pcr
multiplex
turn
around
time
per
sampl
reduc
averag
work
day
tabl
addit
percentag
posit
sampl
also
increas
sinc
time
reason
increas
detect
rate
unclear
may
indic
better
sampl
clinician
could
due
implement
new
c
trachomati
real
time
pcr
method
multiplex
pcr
allow
rapid
differenti
mild
potenti
seriou
caus
conjunct
may
difficult
distinguish
clinic
exampl
hsv
may
result
keratoconjunct
indistinguish
adenoviru
lead
caus
viralinduc
blind
western
world
addit
multiplex
pcr
allow
screen
viral
bacteri
caus
conjunct
import
individu
may
stay
workschool
week
infect
viral
wherea
case
bacteri
infect
c
trachomati
could
return
workschool
hour
initi
antibiot
treatment
although
c
trachomati
may
seriou
caus
conjunct
diagnosi
import
aid
manag
patient
indic
possibl
genit
infect
patient
treat
refer
genitourinari
medicin
gum
clinic
test
offer
case
babi
infect
mother
would
also
refer
test
treatment
